Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Glenn A. Marsh is active.

Publication


Featured researches published by Glenn A. Marsh.


Journal of Virology | 2007

Specific Residues of the Influenza A Virus Hemagglutinin Viral RNA Are Important for Efficient Packaging into Budding Virions

Glenn A. Marsh; Raheleh Hatami; Peter Palese

ABSTRACT A final step in the influenza virus replication cycle is the assembly of the viral structural proteins and the packaging of the eight segments of viral RNA (vRNA) into a fully infectious virion. The process by which the RNA genome is packaged efficiently remains poorly understood. In an approach to analyze how vRNA is packaged, we rescued a seven-segmented virus lacking the hemagglutinin (HA) vRNA (deltaHA virus). This virus could be passaged in cells constitutively expressing HA protein, but it was attenuated in comparison to wild-type A/WSN/33 virus. Supplementing the deltaHA virus with an artificial segment containing green fluorescent protein (GFP) or red fluorescent protein (RFP) with HA packaging regions (45 3′ and 80 5′ nucleotides) partially restored the growth of this virus to wild-type levels. The absence of the HA vRNA in the deltaHA virus resulted in a 40 to 60% reduction in the packaging of the PA, NP, NA, M, and NS vRNAs, as measured by quantitative PCR (qPCR), and the packaging of these vRNAs was partially restored in the presence of GFP/RFP packaging constructs. To further define nucleotides of the HA coding sequence which are important for vRNA packaging, synonymous mutations were introduced into the full-length HA cDNA of influenza A/WSN/33 and A/Puerto Rico/8/34 viruses, and mutant viruses were rescued. qPCR analysis of vRNAs packaged in these mutant viruses identified a key region of the open reading frame (nucleotides 1659 to 1671) that is critical for the efficient packaging of an influenza virus H1 HA segment.


Proceedings of the Royal Society of London B: Biological Sciences | 2014

Ecological dynamics of emerging bat virus spillover

Raina K. Plowright; Peggy Eby; Peter J. Hudson; Ina Smith; David A. Westcott; W. L. Bryden; Deborah Middleton; Peter A. Reid; Rosemary McFarlane; Gerardo Martin; Gary Tabor; Lee F. Skerratt; Dale L. Anderson; Gary Crameri; David Quammen; David Jordan; Paul Freeman; Lin-Fa Wang; Jonathan H. Epstein; Glenn A. Marsh; Nina Y. Kung; Hamish McCallum

Viruses that originate in bats may be the most notorious emerging zoonoses that spill over from wildlife into domestic animals and humans. Understanding how these infections filter through ecological systems to cause disease in humans is of profound importance to public health. Transmission of viruses from bats to humans requires a hierarchy of enabling conditions that connect the distribution of reservoir hosts, viral infection within these hosts, and exposure and susceptibility of recipient hosts. For many emerging bat viruses, spillover also requires viral shedding from bats, and survival of the virus in the environment. Focusing on Hendra virus, but also addressing Nipah virus, Ebola virus, Marburg virus and coronaviruses, we delineate this cross-species spillover dynamic from the within-host processes that drive virus excretion to land-use changes that increase interaction among species. We describe how land-use changes may affect co-occurrence and contact between bats and recipient hosts. Two hypotheses may explain temporal and spatial pulses of virus shedding in bat populations: episodic shedding from persistently infected bats or transient epidemics that occur as virus is transmitted among bat populations. Management of livestock also may affect the probability of exposure and disease. Interventions to decrease the probability of virus spillover can be implemented at multiple levels from targeting the reservoir host to managing recipient host exposure and susceptibility.


Journal of Virology | 2008

Highly Conserved Regions of Influenza A Virus Polymerase Gene Segments Are Critical for Efficient Viral RNA Packaging

Glenn A. Marsh; Raul Rabadan; Arnold J. Levine; Peter Palese

ABSTRACT The genome of the influenza A virus is composed of eight different segments of negative-sense RNA. These eight segments are incorporated into budding virions in an equimolar ratio through a mechanism that is not fully understood. Two different models have been proposed for packaging the viral ribonucleoproteins into newly assembling virus particles: the random-incorporation model and the selective-incorporation model. In the last few years, increasing evidence from many different laboratories that supports the selective-incorporation model has been accumulated. In particular, different groups have shown that some large viral RNA regions within the coding sequences at both the 5′ and 3′ ends of almost every segment are sufficient for packaging foreign RNA sequences. If the packaging regions are crucial for the viability of the virus, we would expect them to be conserved. Using large-scale analysis of influenza A virus sequences, we developed a method of identifying conserved RNA regions whose conservation cannot be explained by population structure or amino acid conservation. Interestingly, the conserved sequences are located within the regions identified as important for efficient packaging. By utilizing influenza virus reverse genetics, we have rescued mutant viruses containing synonymous mutations within these highly conserved regions. Packaging of viral RNAs in these viruses was analyzed by reverse transcription using a universal primer and quantitative PCR for individual segments. Employing this approach, we have identified regions in the polymerase gene segments that, if mutated, result in reductions of more than 90% in the packaging of that particular polymerase viral RNA. Reductions in the level of packaging of a polymerase viral RNA frequently resulted in reductions of other viral RNAs as well, and the results form a pattern of hierarchy of segment interactions. This work provides further evidence for a selective packaging mechanism for influenza A viruses, demonstrating that these highly conserved regions are important for efficient packaging.


PLOS ONE | 2009

Establishment, immortalisation and characterisation of pteropid bat cell lines

Gary Crameri; Shawn Todd; Samantha Grimley; Jennifer A. McEachern; Glenn A. Marsh; Craig Smith; Mary Tachedjian; Carol de Jong; Elena R. Virtue; Meng Yu; Dieter M. Bulach; Jun-Ping Liu; Wojtek P. Michalski; Deborah Middleton; Hume Field; Lin-Fa Wang

Background Bats are the suspected natural reservoir hosts for a number of new and emerging zoonotic viruses including Nipah virus, Hendra virus, severe acute respiratory syndrome coronavirus and Ebola virus. Since the discovery of SARS-like coronaviruses in Chinese horseshoe bats, attempts to isolate a SL-CoV from bats have failed and attempts to isolate other bat-borne viruses in various mammalian cell lines have been similarly unsuccessful. New stable bat cell lines are needed to help with these investigations and as tools to assist in the study of bat immunology and virus-host interactions. Methodology/Findings Black flying foxes (Pteropus alecto) were captured from the wild and transported live to the laboratory for primary cell culture preparation using a variety of different methods and culture media. Primary cells were successfully cultured from 20 different organs. Cell immortalisation can occur spontaneously, however we used a retroviral system to immortalise cells via the transfer and stable production of the Simian virus 40 Large T antigen and the human telomerase reverse transcriptase protein. Initial infection experiments with both cloned and uncloned cell lines using Hendra and Nipah viruses demonstrated varying degrees of infection efficiency between the different cell lines, although it was possible to infect cells in all tissue types. Conclusions/Significance The approaches developed and optimised in this study should be applicable to bats of other species. We are in the process of generating further cell lines from a number of different bat species using the methodology established in this study.


The Journal of Infectious Diseases | 2011

Ebola Reston Virus Infection of Pigs: Clinical Significance and Transmission Potential

Glenn A. Marsh; Jessica Haining; Rachel Robinson; Adam J. Foord; Manabu Yamada; Jennifer A. Barr; Jean Payne; John R. White; Meng Yu; John Bingham; Pierre E. Rollin; Stuart T. Nichol; Lin-Fa Wang; Deborah Middleton

In 2008, Reston ebolavirus (REBOV) was isolated from pigs during a disease investigation in the Philippines. Porcine reproductive and respiratory syndrome virus (PRRSV) and porcine circovirus type 2 (PCV-2) infections were also confirmed in affected herds and the contribution of REBOV to the disease outbreak remains uncertain. We have conducted experimental challenge studies in 5-week-old pigs, with exposure of animals to 10(6) TCID(50) of a 2008 swine isolate of REBOV via either the oronasal or subcutaneous route. Replication of virus in internal organs and viral shedding from the nasopharynx were documented in the absence of clinical signs of disease in infected pigs. These observations confirm not only that asymptomatic infection of pigs with REBOV occurs, but that animals so affected pose a transmission risk to farm, veterinary, and abattoir workers.


PLOS ONE | 2011

Identifying Hendra Virus Diversity in Pteropid Bats

Ina Smith; Alice Broos; Carol de Jong; Anne Zeddeman; Craig A. Smith; Greg A. Smith; Fred Moore; Jennifer A. Barr; Gary Crameri; Glenn A. Marsh; Mary Tachedjian; Meng Yu; Yu Hsin Kung; Lin-Fa Wang; Hume E. Field

Hendra virus (HeV) causes a zoonotic disease with high mortality that is transmitted to humans from bats of the genus Pteropus (flying foxes) via an intermediary equine host. Factors promoting spillover from bats to horses are uncertain at this time, but plausibly encompass host and/or agent and/or environmental factors. There is a lack of HeV sequence information derived from the natural bat host, as previously sequences have only been obtained from horses or humans following spillover events. In order to obtain an insight into possible variants of HeV circulating in flying foxes, collection of urine was undertaken in multiple flying fox roosts in Queensland, Australia. HeV was found to be geographically widespread in flying foxes with a number of HeV variants circulating at the one time at multiple locations, while at times the same variant was found circulating at disparate locations. Sequence diversity within variants allowed differentiation on the basis of nucleotide changes, and hypervariable regions in the genome were identified that could be used to differentiate circulating variants. Further, during the study, HeV was isolated from the urine of flying foxes on four occasions from three different locations. The data indicates that spillover events do not correlate with particular HeV isolates, suggesting that host and/or environmental factors are the primary determinants of bat-horse spillover. Thus future spillover events are likely to occur, and there is an on-going need for effective risk management strategies for both human and animal health.


Emerging Infectious Diseases | 2014

Hendra Virus Vaccine, a One Health Approach to Protecting Horse, Human, and Environmental Health

Deborah Middleton; Jackie Pallister; Reuben Klein; Yan-Ru Feng; Jessica Haining; Rachel Arkinstall; Leah Frazer; Jinan Huang; Nigel Edwards; Mark Wareing; Martin Elhay; Zia Hashmi; John Bingham; Manabu Yamada; Dayna Johnson; John R. White; Adam J. Foord; Hans G. Heine; Glenn A. Marsh; Christopher C. Broder; Lin-Fa Wang

In recent years, the emergence of several highly pathogenic zoonotic diseases in humans has led to a renewed emphasis on the interconnectedness of human, animal, and environmental health, otherwise known as One Health. For example, Hendra virus (HeV), a zoonotic paramyxovirus, was discovered in 1994, and since then, infections have occurred in 7 humans, each of whom had a strong epidemiologic link to similarly affected horses. As a consequence of these outbreaks, eradication of bat populations was discussed, despite their crucial environmental roles in pollination and reduction of the insect population. We describe the development and evaluation of a vaccine for horses with the potential for breaking the chain of HeV transmission from bats to horses to humans, thereby protecting horse, human, and environmental health. The HeV vaccine for horses is a key example of a One Health approach to the control of human disease.


Journal of Immunology | 2011

Type III IFNs in Pteropid Bats: Differential Expression Patterns Provide Evidence for Distinct Roles in Antiviral Immunity

Peng Zhou; Chris Cowled; Shawn Todd; Gary Crameri; Elena R. Virtue; Glenn A. Marsh; Reuben Klein; Zhengli Shi; Lin-Fa Wang; Michelle L. Baker

Bats are known to harbor a number of emerging and re-emerging zoonotic viruses, many of which are highly pathogenic in other mammals but result in no clinical symptoms in bats. The ability of bats to coexist with viruses may be the result of rapid control of viral replication early in the immune response. IFNs provide the first line of defense against viral infection in vertebrates. Type III IFNs (IFN-λs) are a recently identified IFN family that share similar antiviral activities with type I IFNs. To our knowledge, we demonstrate the first functional analysis of type III IFNs from any species of bat, with the investigation of two IFN-λ genes from the pteropid bat, Pteropus alecto. Our results demonstrate that bat type III IFN has similar antiviral activity to type I and III IFNs from other mammals. In addition, the two bat type III IFNs are differentially induced relative to each other and to type I IFNs after treatment or transfection with synthetic dsRNA. Infection with the bat paramyxovirus, Tioman virus, resulted in no upregulation of type I IFN production in bat splenocytes but was capable of inducing a type III IFN response in three of the four bats tested. To our knowledge, this is the first report to describe the simultaneous suppression of type I IFN and induction of type III IFN after virus infection. These results may have important implications for the role of type III IFNs in the ability of bats to coexist with viruses.


Emerging Infectious Diseases | 2011

Experimental infection of horses with Hendra virus/Australia/horse/2008/Redlands.

Glenn A. Marsh; Jessica Haining; Timothy J. Hancock; Rachel Robinson; Adam J. Foord; Jennifer A. Barr; Shane Riddell; Hans G. Heine; John R. White; Gary Crameri; Hume E. Field; Lin-Fa Wang; Deborah Middleton

Early consideration of HeV and institution of infection control are critical for reducing human risk.


Journal of Virology | 2013

Novel, Potentially Zoonotic Paramyxoviruses from the African Straw-Colored Fruit Bat Eidolon helvum

Kate S. Baker; Shawn Todd; Glenn A. Marsh; Gary Crameri; Jennifer A. Barr; Alexandra O. Kamins; Alison J. Peel; Meng Yu; David T. S. Hayman; Behzad Nadjm; George Mtove; Benjamin Amos; Hugh Reyburn; Edward Nyarko; Richard Suu-Ire; Pablo R. Murcia; Andrew A. Cunningham; J. L. N. Wood; Lin-Fa Wang

ABSTRACT Bats carry a variety of paramyxoviruses that impact human and domestic animal health when spillover occurs. Recent studies have shown a great diversity of paramyxoviruses in an urban-roosting population of straw-colored fruit bats in Ghana. Here, we investigate this further through virus isolation and describe two novel rubulaviruses: Achimota virus 1 (AchPV1) and Achimota virus 2 (AchPV2). The viruses form a phylogenetic cluster with each other and other bat-derived rubulaviruses, such as Tuhoko viruses, Menangle virus, and Tioman virus. We developed AchPV1- and AchPV2-specific serological assays and found evidence of infection with both viruses in Eidolon helvum across sub-Saharan Africa and on islands in the Gulf of Guinea. Longitudinal sampling of E. helvum indicates virus persistence within fruit bat populations and suggests spread of AchPVs via horizontal transmission. We also detected possible serological evidence of human infection with AchPV2 in Ghana and Tanzania. It is likely that clinically significant zoonotic spillover of chiropteran paramyxoviruses could be missed throughout much of Africa where health surveillance and diagnostics are poor and comorbidities, such as infection with HIV or Plasmodium sp., are common.

Collaboration


Dive into the Glenn A. Marsh's collaboration.

Top Co-Authors

Avatar

Lin-Fa Wang

National University of Singapore

View shared research outputs
Top Co-Authors

Avatar

Deborah Middleton

Australian Animal Health Laboratory

View shared research outputs
Top Co-Authors

Avatar

Shawn Todd

Australian Animal Health Laboratory

View shared research outputs
Top Co-Authors

Avatar

Gary Crameri

Australian Animal Health Laboratory

View shared research outputs
Top Co-Authors

Avatar

Jennifer A. Barr

Australian Animal Health Laboratory

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ina Smith

Australian Animal Health Laboratory

View shared research outputs
Top Co-Authors

Avatar

Christopher C. Broder

Uniformed Services University of the Health Sciences

View shared research outputs
Top Co-Authors

Avatar

Jessica Haining

Australian Animal Health Laboratory

View shared research outputs
Top Co-Authors

Avatar

Meng Yu

Australian Animal Health Laboratory

View shared research outputs
Researchain Logo
Decentralizing Knowledge